ADC Linker Pharma Service for Global Pharmaceutical Projects

As a Manufacturer & Solution Provider, Lianhe Aigen delivers ADC Linker Pharma Service as part of our integrated ADC CDMO Services, supporting global pharmaceutical companies from early-stage development to commercial manufacturing.

Operating under an NDA-based collaboration model, we provide customized linker development and manufacturing solutions aligned with global regulatory expectations. Our integrated platform enables reliable, scalable, and risk-controlled delivery across the ADC value chain.

What We Offer

Our ADC Linker Pharma Service is designed to support the development and manufacturing of linker intermediates used in antibody-drug conjugates, combining process development, scale-up, and production within a unified system.

We focus on delivering:

• Custom ADC linker development services for early-stage research and process validation
• cGMP-compliant linker manufacturing for clinical and commercial supply
• Scalable linker production ensuring consistency across batches
• Confidential, NDA-based project execution for proprietary molecules

This service supports preclinical ADC linker supply, clinical-stage linker manufacturing, and commercial ADC linker production, ensuring continuity from development to long-term supply.

ADC Linker Development & Manufacturing Capabilities

Our ADC Linker Pharma Service integrates development and manufacturing capabilities tailored for complex small molecule linkers:

• ADC linker process development and optimization for reproducible manufacturing
• Scale-up capability for linker intermediates and drug-linker components
• Consistent and controlled production systems to ensure batch-to-batch reliability
• Support for complex linker structures used in targeted ADC therapies

We emphasize process robustness, scalability, and manufacturability, ensuring linkers can transition efficiently from laboratory development to commercial production.

ADC Linker Services by Development Stage

Preclinical ADC Linker Supply

• Custom linker synthesis for early-stage research
• Small-scale, reproducible production
• Support for preclinical ADC development projects

Clinical-Stage ADC Linker Manufacturing

• Process-controlled manufacturing for clinical trials
• Support for IND-enabling linker production
• Improved process consistency and quality control

Commercial ADC Linker Production

• Scalable manufacturing systems for long-term supply
• Stable and reproducible production processes
• Support for commercial-scale ADC linker manufacturing

Integrated CRDMO Capability

Our ADC Linker Pharma Service is supported by a fully integrated platform:

• From starting materials and intermediates to API-related components
• Integrated Small Molecules CDMO Services and ADC development support
• Seamless transition from process development to commercial manufacturing

This integrated capability reduces supply chain complexity and supports efficient, long-term project execution.

Quality & Compliance

All ADC Linker Pharma Services are delivered under a structured quality system aligned with global pharmaceutical standards:

• cGMP-compliant manufacturing environment
• Quality systems aligned with international regulatory expectations
• Full traceability of raw materials, intermediates, and production processes
• Structured change control and deviation management systems
• Support for regulatory submissions and customer audits

Our objective is to ensure every linker product is consistent, compliant, and suitable for global pharmaceutical applications.

Applications of ADC Linkers

Lianhe Aigen provides linkers suitable for a broad range of therapeutic applications, including:

Oncology: Targeted delivery of cytotoxic agents for cancer treatment.

Autoimmune Diseases: Precision-targeted biologics for immune modulation.

Infectious Diseases: ADCs for pathogen-specific targeting.

How We Work

We follow a structured and transparent collaboration model:

1. NDA-based project onboarding
2. Technical evaluation and feasibility assessment
3. ADC linker process development and optimization
4. Scale-up and manufacturing of linker intermediates
5. Delivery and long-term supply support

This approach ensures confidentiality, controlled execution, and reliable delivery at every stage.

Why Partner With Lianhe Aigen

As a Manufacturer & Solution Provider, Lianhe Aigen combines:

• Technology & Innovation
  Continuous development of scalable solutions for complex linker molecules
• Process Development Expertise
  Strong capabilities in route design, optimization, and scale-up
• Project Management Capability
  Structured coordination ensuring timelines, quality, and risk control
• Compliance Support
  Alignment with global regulatory frameworks and audit requirements
• Quality Management System
  Established systems ensuring consistency and traceability

Backed by a solid manufacturing foundation, we provide stable, scalable, and long-term ADC linker supply solutions.

Who We Serve

Our ADC Linker Pharma Service supports pharmaceutical companies across:

• United States
• Europe
• Japan

Serving:

• Global pharmaceutical companies
• Biotechnology companies
• Emerging biotech innovators

We focus on building long-term partnerships for innovative ADC development projects.

Empowering ADC Innovations with Lianhe Aigen

As a trusted partner in the pharmaceutical industry, Lianhe Aigen is committed to accelerating the development of ADC therapies through innovative linker chemistries and world-class manufacturing capabilities. By delivering high-quality, reliable solutions, we enable pharmaceutical innovators to bring life-changing therapies to patients worldwide.